[1]
2026. A Comparative Study of Regulatory Guidelines, Digital Pharmacovigilance, and Software as a Medical Device across High- and Low-to-Middle-Income Countries: Research Article. Journal of Pharma Insights and Research. 4, 2 (Apr. 2026), 304–319. DOI:https://doi.org/10.69613/mdb50d20.